NICE Ltd.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $NICE in the last 30 days.
See all $NICE insider activity →Oppenheimer upgraded NICE to Outperform, citing improved financials and easing AI disruption fears. The firm set a $150 price target, and shares rose 4% in early trading.
Analysts made several calls: UBS kept Apple neutral citing stable iPhone wait times. Wells Fargo upgraded Pinnacle Financial and downgraded Ally Financial. Deutsche Bank initiated FormFactor as buy. William Blair initiated CoreWeave and Nebius Group as outperform. Bank of America reiterated Nvidia, Intel, Marvell, Micron, and Lam Research as buy. Citi initiated Nuvation Bio as buy and downgraded Moderna to sell. HSBC upgraded Target to buy. Morgan Stanley reiterated Tesla as equal weight.
Wall Street analysts issued upgrades, downgrades, and initiations for several companies. Notable upgrades include Target (TGT) to Buy at HSBC with a $190 target, and Grocery Outlet (GO) to Buy at Bank of America with a $15 target. Downgrades include Ally Financial (ALLY) to Equal Weight at Wells Fargo with a $42 target, and Moderna (MRNA) to Sell at Citigroup with an $80 target.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning NICE (NICE Ltd.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.
Recent NICE coverage spans financial news, market movers and mergers & acquisitions.
The upgrade and new target are likely to drive further buying pressure.
Outperform rating suggests upside.
Outperform rating could lift shares.
Potential acquisition could boost Nice's valuation and drive short‑term buying.
Potential acquisition could boost Nice's valuation and trigger share price movement.
AlphAI scores every news story that mentions NICE with an AI model for sentiment and relevance, and aggregates insider trades from NICE Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Oppenheimer upgraded NICE to Outperform, citing improved financials and easing AI disruption fears. The firm set a $150 price target, and shares rose 4% in early trading.
1 min readAnalysts made several calls: UBS kept Apple neutral citing stable iPhone wait times. Wells Fargo upgraded Pinnacle Financial and downgraded Ally Financial. Deutsche Bank initiated FormFactor as buy. William Blair initiated CoreWeave and Nebius Group as outperform. Bank of America reiterated Nvidia, Intel, Marvell, Micron, and Lam Research as buy. Citi initiated Nuvation Bio as buy and downgraded Moderna to sell. HSBC upgraded Target to buy. Morgan Stanley reiterated Tesla as equal weight.
3 min readWall Street analysts issued upgrades, downgrades, and initiations for several companies. Notable upgrades include Target (TGT) to Buy at HSBC with a $190 target, and Grocery Outlet (GO) to Buy at Bank of America with a $15 target. Downgrades include Ally Financial (ALLY) to Equal Weight at Wells Fargo with a $42 target, and Moderna (MRNA) to Sell at Citigroup with an $80 target.
2 min readTel Aviv Stock Exchange indices fell, with Tel Aviv 35 down 0.26% and BlueTech Global down 0.12%. Nice gained 1.68% on acquisition rumors, while Camtek dropped 2.73%. Banking and retail sectors saw declines. Turnover was NIS 3.84B in equities and NIS 6.63B in bonds.
1 min readBrookfield is in talks to acquire Actimize from NICE for $2 billion, though the deal is not finalized. NICE, with a $6.9 billion market cap, has seen low single-digit stock gains this year. Brookfield manages over $1 trillion in assets and has a $73.5 billion market cap. NICE reported Q2 2026 revenue of $782 million, with $83.2 million in net profit.
2 min readNICE Ltd. (NICE) shares rose after an analyst upgraded the stock to Buy and the company announced plans to sell its Actimize unit for $2B to focus on AI and cloud platforms. The rally follows a strong Q2 earnings beat and new customer wins. The company has strong margins and cash generation but faces challenges in revenue conversion and profit pressure.
2 min readNiCE (NICE) announced that Merlin Entertainments is using its CXone AI platform to enhance guest experiences across its global attractions, including LEGOLAND and Madame Tussauds. Merlin reported improvements in guest satisfaction and issue resolution rates. The partnership aims to streamline guest interactions and improve operational efficiency.
1 min readThe Tel Aviv Stock Exchange rose, with the Tel Aviv 35 Index up 1.30% to 4,201.89 points. Banks and chip companies led gains, while Palo Alto Networks fell 8.39% after earnings. Turnover was NIS 5.12 billion in equities. The shekel strengthened against the dollar and euro.
2 min readNICE (Nasdaq: NICE) said Bluecrest, a UK health intelligence firm, deployed the NiCE CXone platform with SVL Business Solutions to modernize its contact center. The release cites £250,000 annual savings, a 94% call answer rate, 100% interaction analysis, and coaching-driven product conversations rising from 10% to 70%, contributing to 2,200+ subscriptions.
4 min readFriday on the Tel Aviv Stock Exchange, major indices declined. Tel Aviv 35 fell 0.33% to 4,202.63 and Tel Aviv 125 fell 0.31% to 4,074.63. Defense and renewable energy sector indices dropped, while chemicals rubber and plastics rose. FX rates weakened versus the dollar and euro. Bank Hapoalim rose 0.31%, Tower Semiconductor fell 4.35%, Teva fell 2.28%.
3 min read
